Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model (2022)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; SINGULANI, MONIQUE PATRICIO - FM
- Unidades: IQ; ICB; FM
- DOI: 10.1007/s12035-022-02723-8
- Subjects: FISIOLOGIA; NEUROBIOLOGIA; MODELOS ANIMAIS DE DOENÇAS; DOENÇA DE PARKINSON; MESENCÉFALO; GÂNGLIOS; RECEPTORES DE DOPAMINA; CAMUNDONGOS; IMUNOHISTOQUÍMICA; IMMUNOBLOTTING
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título: Molecular Neurobiology
- ISSN: 1559-1182
- Volume/Número/Paginação/Ano: v. 59, p. 1543–1559, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERREIRA, Ana Flávia Fernandes et al. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model. Molecular Neurobiology, v. 59, p. 1543–1559, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12035-022-02723-8. Acesso em: 27 dez. 2025. -
APA
Ferreira, A. F. F., Singulani, M. P., Ulrich, H., Feng, Z. -P., Sun, H. -S., & Britto, L. R. G. de. (2022). Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model. Molecular Neurobiology, 59, 1543–1559. doi:10.1007/s12035-022-02723-8 -
NLM
Ferreira AFF, Singulani MP, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model [Internet]. Molecular Neurobiology. 2022 ; 59 1543–1559.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s12035-022-02723-8 -
Vancouver
Ferreira AFF, Singulani MP, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model [Internet]. Molecular Neurobiology. 2022 ; 59 1543–1559.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s12035-022-02723-8 - Mitochondrial abnormalities in neurological disorders
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease
- The role of interleukin-17 in neurological disorders
- Neuroplasticity induced by the retention period of a complex motor skill learning in rats
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
Informações sobre o DOI: 10.1007/s12035-022-02723-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
